ADAM10 and cancer: The infiltration scores of 6 immune cells including lymphocyte B, lymphocyte T CD4, macrophage, lymphocyte T CD8, neutrophil, and dendritic cells were reappraised for 9,405 tumor samples in 38 cancer types, 6 immune cells including SC, MHC, endothelial cell, induced pluripotent stem cells, CP and AZ, and 22 class immunocytes in 10,179 tumor specimens from 44 cancers based on the ADAM10 gene expression.